- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07942636
EMST 150 Training in Mild-Moderate OSA
Evaluating the Efficacy and Feasibility of Combined Expiratory Muscle Strength Training (EMST 150) and Oropharyngeal Myofunctional Therapy in Patients With Mild-to-Moderate Obstructive Sleep Apnea.
Obstructive Sleep Apnea is a condition in which the upper airway repeatedly becomes blocked during sleep, often due to weakness or collapse of the upper airway throat muscles. The purpose of this study is to evaluate whether combining a handheld breathing device (Expiratory Muscle Strength Training (EMST 150)) with structured, speech-language pathology-Guided mouth and throat exercises can help strengthen the muscles that keep the airway open, reduce snoring, and reduce sleep apnea severity while improving overall sleep quality. Participation in this study will last about 3 months. This includes a 5-week home breathing exercise program, two in-person clinic visits (at the beginning of the study and at Month 3), and two short phone check-ins.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Thomaz Fleury Curado, MD
- Numéro de téléphone: 216-844-1716
- E-mail: thomaz.fleurycurado@uhhospitals.org
Lieux d'étude
-
-
Ohio
-
Cleveland, Ohio, États-Unis, 44106
- University Hospitals Cleveland Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Clinical diagnosis of Mild-to-Moderate OSA (5<AHI<30 events/hour)
- Patient willingness and physical capability to perform threshold-based respiratory exercises and daily oral myofunctional exercises.
- Documented failure, intolerance (defined as regular use < 4 hours/night), or patient refusal of standard therapies, including Continuous Positive Airway Pressure (CPAP) and surgical interventions.
Exclusion Criteria:
- Severe OSA (AHI>30 events/hour)
- Active asthma, severe or poorly controlled asthma with low symptom perception, or severe chronic obstructive pulmonary disease (COPD)
- Uncontrolled hypertension, defined as resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg at screening, or any change in antihypertensive medication within the past 30 days, or significant cardiovascular disease.
- Recent esophageal surgery, recent abdominal surgery, or presence of an abdominal hernia.
- History of spontaneous pneumothorax, or incomplete recovery/healing following traumatic pneumothorax or rib fracture.
- History of lung transplantation or lung resection.
- Current tracheostomy or unhealed tracheostomy stoma.
- Presence of a cerebrospinal fluid (CSF) drain or active intracranial pressure monitoring.
- Active epistaxis (frequent/severe nosebleeds) or active hemoptysis within the past 30 days.
- Tympanic membrane perforation (ruptured eardrum) or active inner/middle ear pathology.
- Unrelated or uncontrolled gastroesophageal reflux disease (GERD).
- Known or suspected pregnancy.
- Active use of CPAP, mandibular advancement device (MAD), or hypoglossal nerve stimulation (HGNS) during the study period.
- Any acute medical condition or clinical situation where generating intrathoracic, intro-abdominal, or intracranial pressure (similar to Valsalva maneuver) is clinically contraindicated.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Participants with Obstructive Sleep Apnea (OSA)
Adult participants diagnosed with mild-to-moderate obstructive OSA. |
Participants utilize the EMST 150 device to strengthen expiratory and upper airway musculature. During training, participants inhale deeply and exhale forcefully through the mouthpiece again calibrated resistance while maintaining an airtight lip seal to overcome the target threshold pressure. Participants perform structured oral motor exercises :
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI)
Délai: Baseline, 3 months
|
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire that evaluates overall sleep quality and disturbances over a one-month time interval. With higher scores indicating poor sleep quality. |
Baseline, 3 months
|
|
Change in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS)
Délai: Baseline, 3 months
|
The Epworth Sleepiness Scale (ESS) is a short, self-administered questionnaire used to measure a person's general level of daytime sleepiness and likelihood of dozing off in everyday situations. Scored on a scale from 0 would never doze, to 3 high chance of dozing. |
Baseline, 3 months
|
|
Snore score as measured by smartphone application monitoring.
Délai: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Percentage of snoring sleep time as measured by smartphone application monitoring.
Délai: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Noise intensity in decibels as measured by smartphone application monitoring.
Délai: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Change in Isometric maximal tongue pressure (kPa) as measured by the Iowa Oral Performance Instrument (IOPI)
Délai: Baseline, 3 months
|
The Iowa Oral Performance Instrument (IOPI) is a portable, evidence-based medical device used to objectively measure, document, and train lip and tongue strength and endurance. The device digitally records maximum isometric pressure in kilopascals |
Baseline, 3 months
|
|
Change in tongue muscle endurance as measured by time in seconds sustained at 50% maximal pressure.
Délai: Baseline, 3 months
|
Time in seconds sustained at 50% maximal pressure. |
Baseline, 3 months
|
|
Change in Apnea-Hypopnea Index (AHI)
Délai: Baseline, 3 months
|
The apnea-hypopnea index (AHI) is the average number of breathing pauses (apneas) and shallow breathing events (hypopneas) that occur per hour of sleep, with higher scores indicating greater sleep apnea severity. |
Baseline, 3 months
|
|
Change in Maximum Expiratory Pressure (MEP)
Délai: Baseline, 3 months
|
MEP is the highest positive pressure generated by a person during a forced exhalation against a blocked airway. It measures the strength of the expiratory muscles, including the abdominal and internal intercostal muscles, and helps evaluate cough efficiency and neuromuscular function. Lower scores indicate generalized respiratory muscle weakness, chronic obstructive pulmonary disease (COPD), or neuromuscular conditions like myasthenia gravis or Guillain-Barré syndrome. |
Baseline, 3 months
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Thomaz Fleury Curado, MD, University Hospitals Cleveland Medical Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STUDY20261102
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .